ID CANB2_HUMAN Reviewed; 170 AA. AC Q96LZ3; Q5VTR4; Q7Z4V8; Q8WYJ4; DT 13-SEP-2004, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 04-NOV-2026, entry version 182. DE RecName: Full=Calcineurin subunit B type 2; DE AltName: Full=Calcineurin B-like protein; DE Short=CBLP; DE AltName: Full=Calcineurin BII; DE Short=CNBII; DE AltName: Full=PPP3R1-like; DE AltName: Full=Protein phosphatase 2B regulatory subunit 2; DE AltName: Full=Protein phosphatase 3 regulatory subunit B beta isoform; GN Name=PPP3R2; Synonyms=CBLP, PPP3RL; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Testis; RX PubMed=15865209; DOI=10.1007/s11033-004-4250-4; RA Liu L., Zhang J., Yuan J., Dang Y., Yang C., Chen X., Xu J., Yu L.; RT "Characterization of a human regulatory subunit of protein phosphatase 3 RT gene (PPP3RL) expressed specifically in testis."; RL Mol. Biol. Rep. 32:41-45(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Guo J.H., She X.Y., Dai F.Y., Yu L.; RT "cDNA cloning of a novel calcineurin B-like protein (CBLP)."; RL Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Tu Q., Yu L., Bi A., Zhang H., He W., Zhao S.; RT "Cloning of a novel human cDNA, CNBII, whose product shows significant RT homology to calcineurin B."; RL Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Testis; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP INTERACTION WITH SPATA33. RX PubMed=34446558; DOI=10.1073/pnas.2106673118; RA Miyata H., Oura S., Morohoshi A., Shimada K., Mashiko D., Oyama Y., RA Kaneda Y., Matsumura T., Abbasi F., Ikawa M.; RT "SPATA33 localizes calcineurin to the mitochondria and regulates sperm RT motility in mice."; RL Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021). CC -!- FUNCTION: Regulatory subunit of calcineurin, a calcium-dependent, CC calmodulin stimulated protein phosphatase. Confers calcium sensitivity. CC {ECO:0000250|UniProtKB:P63098}. CC -!- SUBUNIT: Forms a complex composed of a calmodulin-dependent catalytic CC subunit (also known as calcineurin A) and a regulatory Ca(2+)-binding CC subunit (also known as calcineurin B). There are three catalytic CC subunits, each encoded by a separate gene (PPP3CA, PPP3CB, and PPP3CC) CC and two regulatory subunits which are also encoded by separate genes CC (PPP3R1 and PPP3R2) (By similarity). Interacts with SPATA33 (via PQIIIT CC motif) (PubMed:34446558). {ECO:0000250|UniProtKB:P63098, CC ECO:0000269|PubMed:34446558}. CC -!- INTERACTION: CC Q96LZ3; Q12800: TFCP2; NbExp=3; IntAct=EBI-3906025, EBI-717422; CC -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q63811}. CC Note=Localizes in the mitochondria in a SPATA33-dependent manner. CC {ECO:0000250|UniProtKB:Q63811}. CC -!- TISSUE SPECIFICITY: Testis-specific. {ECO:0000269|PubMed:15865209}. CC -!- MISCELLANEOUS: This protein has four functional calcium-binding sites. CC {ECO:0000250|UniProtKB:P63098}. CC -!- SIMILARITY: Belongs to the calcineurin regulatory subunit family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH30595.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAH66299.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAP57772.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAB71521.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=EAW58961.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF145026; AAP97278.1; -; mRNA. DR EMBL; AF400667; AAP57772.1; ALT_INIT; mRNA. DR EMBL; AF085237; AAL40395.1; -; mRNA. DR EMBL; AK057524; BAB71521.1; ALT_INIT; mRNA. DR EMBL; AL591377; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471105; EAW58961.1; ALT_INIT; Genomic_DNA. DR EMBL; BC030595; AAH30595.1; ALT_INIT; mRNA. DR EMBL; BC066299; AAH66299.1; ALT_INIT; mRNA. DR CCDS; CCDS6759.2; -. DR RefSeq; NP_671709.2; NM_147180.4. DR AlphaFoldDB; Q96LZ3; -. DR SMR; Q96LZ3; -. DR BioGRID; 111527; 32. DR ComplexPortal; CPX-1002; Calcineurin-Calmodulin complex, beta-R2 variant. DR ComplexPortal; CPX-1048; Calcineurin-Calmodulin complex, alpha-R2 variant. DR ComplexPortal; CPX-1050; Calcineurin-Calmodulin complex, gamma-R2 variant. DR ComplexPortal; CPX-1114; Calcineurin-Calmodulin-AKAP5 complex, alpha-R2 variant. DR ComplexPortal; CPX-1116; Calcineurin-Calmodulin-AKAP5 complex, beta-R2 variant. DR ComplexPortal; CPX-1118; Calcineurin-Calmodulin-AKAP5 complex, gamma-R2 variant. DR FunCoup; Q96LZ3; 1117. DR IntAct; Q96LZ3; 28. DR NDEx; IQUERY-CP-PPP3R2; 9 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000498330; -. DR DrugBank; DB00091; Cyclosporine. DR DrugBank; DB11693; Voclosporin. DR CarbonylDB; Q96LZ3; -. DR iPTMnet; Q96LZ3; -. DR PhosphoSitePlus; Q96LZ3; -. DR BioMuta; PPP3R2; -. DR DMDM; 52000731; -. DR jPOST; Q96LZ3; -. DR MassIVE; Q96LZ3; -. DR PaxDb; 9606-ENSP00000498330; -. DR PeptideAtlas; Q96LZ3; -. DR ProteomicsDB; 77271; -. DR Antibodypedia; 29196; 204 antibodies from 29 providers. DR DNASU; 5535; -. DR Ensembl; ENST00000374806.2; ENSP00000363939.2; ENSG00000188386.8. DR GeneID; 5535; -. DR KEGG; hsa:5535; -. DR MANE-Select; ENST00000374806.2; ENSP00000363939.2; NM_147180.4; NP_671709.2. DR UCSC; uc004bbr.3; human. DR AGR; HGNC:9318; -. DR ClinPGx; PA33682; -. DR CTD; 5535; -. DR DisGeNET; 5535; -. DR GeneCards; PPP3R2; -. DR HGNC; HGNC:9318; PPP3R2. DR HPA; ENSG00000188386; Tissue enriched (testis). DR MIM; 613821; gene. DR OpenTargets; ENSG00000188386; -. DR VEuPathDB; HostDB:ENSG00000188386; -. DR eggNOG; KOG0034; Eukaryota. DR GeneTree; ENSGT00940000165130; -. DR HOGENOM; CLU_061288_10_1_1; -. DR InParanoid; Q96LZ3; -. DR OMA; AEMCAHF; -. DR OrthoDB; 191686at2759; -. DR PAN-GO; Q96LZ3; 4 GO annotations based on evolutionary models. DR PhylomeDB; Q96LZ3; -. DR BRENDA; 3.1.3.16; 2681. DR PathwayCommons; Q96LZ3; -. DR SignaLink; Q96LZ3; -. DR Agora; ENSG00000188386; -. DR BioGRID-ORCS; 5535; 11 hits in 1147 CRISPR screens. DR GeneWiki; PPP3R2; -. DR GenomeRNAi; 5535; -. DR Pharos; Q96LZ3; Tbio. DR PRO; PR:Q96LZ3; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; Q96LZ3; protein. DR Bgee; ENSG00000188386; Expressed in adult organism and 33 other cell types or tissues. DR ExpressionAtlas; Q96LZ3; baseline and differential. DR GO; GO:0005955; C:calcineurin complex; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; NAS:ComplexPortal. DR GO; GO:0005739; C:mitochondrion; ISS:UniProtKB. DR GO; GO:0008287; C:protein serine/threonine phosphatase complex; NAS:ComplexPortal. DR GO; GO:0097225; C:sperm midpiece; IEA:Ensembl. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0008597; F:calcium-dependent protein serine/threonine phosphatase regulator activity; IDA:MGI. DR GO; GO:0019902; F:phosphatase binding; IBA:GO_Central. DR GO; GO:0097720; P:calcineurin-mediated signaling; IBA:GO_Central. DR GO; GO:1905949; P:negative regulation of calcium ion import across plasma membrane; NAS:ComplexPortal. DR GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; NAS:ComplexPortal. DR GO; GO:1905665; P:positive regulation of calcium ion import across plasma membrane; NAS:ComplexPortal. DR CDD; cd00051; EFh; 1. DR FunFam; 1.10.238.10:FF:000047; Calcineurin subunit B type 1; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR PANTHER; PTHR45942; PROTEIN PHOSPATASE 3 REGULATORY SUBUNIT B ALPHA ISOFORM TYPE 1; 1. DR Pfam; PF13499; EF-hand_7; 2. DR PRINTS; PR00450; RECOVERIN. DR SMART; SM00054; EFh; 4. DR SUPFAM; SSF47473; EF-hand; 1. DR PROSITE; PS00018; EF_HAND_1; 4. DR PROSITE; PS50222; EF_HAND_2; 4. PE 1: Evidence at protein level; KW Calcium; Lipoprotein; Metal-binding; Mitochondrion; Myristate; KW Proteomics identification; Reference proteome; Repeat. FT INIT_MET 1 FT /note="Removed" FT CHAIN 2..170 FT /note="Calcineurin subunit B type 2" FT /id="PRO_0000073499" FT DOMAIN 18..46 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 50..85 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 87..122 FT /note="EF-hand 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 128..163 FT /note="EF-hand 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT REGION 131..136 FT /note="Calcineurin A binding" FT /evidence="ECO:0000250|UniProtKB:P63098" FT BINDING 31 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 33 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 35 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 37 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 42 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 63 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 65 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 67 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 69 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 74 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 100 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 102 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 104 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 106 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 111 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 141 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 143 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 145 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 147 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 152 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT SITE 118 FT /note="Interaction with PxVP motif in substrates of the FT catalytic subunit" FT /evidence="ECO:0000250|UniProtKB:P63098" FT SITE 122 FT /note="Interaction with PxVP motif in substrates of the FT catalytic subunit" FT /evidence="ECO:0000250|UniProtKB:P63098" FT LIPID 2 FT /note="N-myristoyl glycine" FT /evidence="ECO:0000250|UniProtKB:P63098" FT CONFLICT 16 FT /note="D -> N (in Ref. 3; AAL40395)" FT /evidence="ECO:0000305" SQ SEQUENCE 170 AA; 19533 MW; 322F9CA4123BA2C3 CRC64; MGNEASYPAE MCSHFDNDEI KRLGRRFKKL DLDKSGSLSV EEFMSLPELR HNPLVRRVID VFDTDGDGEV DFKEFILGTS QFSVKGDEEQ KLRFAFSIYD MDKDGYISNG ELFQVLKMMV GNNLTDWQLQ QLVDKTIIIL DKDGDGKISF EEFSAVVRDL EIHKKLVLIV //